Categories: Wire Stories

Global Japanese Encephalitis Vaccines Market (2021 to 2025) – Featuring Adimmune, Bharat Biotech and Sanofi Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Japanese Encephalitis Vaccines Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering.

The publisher has been monitoring the Japanese encephalitis vaccines market and it is poised to grow by $54.39 million during 2021-2025 progressing at a CAGR of 6% during the forecast period.

The report on Japanese encephalitis vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the inclusion in national immunization plan and strategic alliances.

The Japanese encephalitis vaccines market analysis includes type segment and geographical landscapes. This study identifies the growing number of awareness campaigns as one of the prime reasons driving the Japanese encephalitis vaccines market growth during the next few years.

Companies Mentioned

  • Adimmune Corp.
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • KM Biologics Co. Ltd.
  • Medigen Inc.
  • Panacea Biotec Ltd
  • Sanofi
  • Shandong Hengye Biotechnology Co. Ltd.
  • VA Bio+Tech Park
  • Valneva SE

The report on Japanese encephalitis vaccines market covers the following areas:

  • Japanese encephalitis vaccines market sizing
  • Japanese encephalitis vaccines market forecast
  • Japanese encephalitis vaccines market industry analysis

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Key Topics Covered:

1. Executive Summary

  • Market Overview

2. Market Landscape

  • Market ecosystem
  • Value chain analysis

3. Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 – 2025

4. Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

5. Market Segmentation by Type

  • Market segments
  • Comparison by Type
  • Inactivated vaccines – Market size and forecast 2020-2025
  • Recombinant vaccines – Market size and forecast 2020-2025
  • Live attenuated vaccines – Market size and forecast 2020-2025
  • Market opportunity by Type

6. Customer landscape

7. Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • Asia – Market size and forecast 2020-2025
  • ROW – Market size and forecast 2020-2025
  • Europe – Market size and forecast 2020-2025
  • North America – Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

8. Vendor Landscape

  • Overview
  • Landscape disruption

9. Vendor Analysis

  • Vendors covered
  • Market positioning of vendors

10. Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/zg1m8q

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Alex

Recent Posts

Oasis Calls for CEO Dismissal, Submits Shareholder Proposals for New Directors at Hokuetsu AGM (Securities Code: 3865 JT)

*Oasis proposes dismissal of Hokuetsu CEO Sekio Kishimoto at upcoming AGM * Oasis nominates five…

35 mins ago

Seadrill Announces Two New Drillship Commitments

HAMILTON, Bermuda--(BUSINESS WIRE)--Seadrill Limited (“Seadrill” or the “Company”) (NYSE & OSE: SDRL) today announced contract…

3 hours ago

Kasada Secures #4 Spot on Australia’s Best Workplaces™ in Technology List for 2024

Dedication to Fostering a Culture of Care, Innovation, and Impact Drives Global Growth and Recognition…

3 hours ago

GAMCO Board Declares Special Dividend of $0.20 per share and Regular Quarterly Dividend of $0.04 per share

GREENWICH, Conn., May 07, 2024 (GLOBE NEWSWIRE) -- GAMCO Investors, Inc. (“GAMI”) (OTCQX: GAMI) announced…

4 hours ago

Coeur to Participate in Upcoming Canaccord Global Metals & Mining Conference

CHICAGO--(BUSINESS WIRE)--Coeur Mining, Inc.’s (“Coeur” or the “Company”) (NYSE: CDE) Senior Vice President and Chief…

4 hours ago

LEO Pharma Announces Topline Results of Phase 3 Trial in China for Enstilar® (LEO 90100) Demonstrating Superiority in Adult Chinese Subjects With Stable Plaque Psoriasis

Enstilar® (LEO 90100) showed superiority over Daivobet® ointment in primary and both secondary endpoints in…

6 hours ago